Applied Materials
This is the archived full research. Read the story
It makes the machines that build computer chips, the tools that lay down, etch away, polish and measure each layer, and services the ones already running in chip factories.
The scores
Growth3/4 ↑
Revenue is accelerating hard, but the record is a year old: fiscal 2025 and 2024 grew 4.4% and 2.5%, on customers' own capital budgets.
Business quality3/4 →
A rival's own filing states the qualification lock-in, but it is held per step per node, and China's entrants already take the trailing-edge tools.
Financial position4/4 →
Cash and investments are more than twice total debt, nothing is drawn on the facilities, and operating cash covered capital spending, dividends and buybacks.
Execution record3/4 →
Eight consecutive beats and a buyback paused at the high, but a $253M export-controls settlement and continuing subpoenas keep it below the top level.
Per share capture4/4 ↓
Repurchases still exceed stock compensation and the count is shrinking, but at 3 million shares this year against 25 million last year.
Potential2/4 ↑
The upside is a bigger version of today and rests on customers' own annual capital decisions, behind one cancellable quarter of contracted equipment orders.
Risk profile2/4 →
Two unnamed customers are about a third of sales, and 28% ships to China under export licences a single Commerce rule can withdraw.
Valuation3/4 ↓
About 31.3 times earnings, 94% of a three-stage value near $422 at an 8% return: fair, inside the 20% margin.
Evidence quality3/4 →
Every load-bearing figure is filed and reconciles, but the only contracted equipment orders anyone outside can check are now eleven months old.
The Verdict
We rate Applied Materials Neutral. It makes the machines chipmakers need to build each layer of a chip, and every operating number is at a record, so the business is solid. The price sits a little under our value on the analysts' path, but not by our cushion, and the profit is flattered by a tax rate that halved, while cash has lagged: profit rose 44% last year and free cash flow 9%, as unpaid customer bills grew. It is a peak price for peak profit, with China sales under licences that can be withdrawn. Cash catching up with the earnings would make it Attractive.
The long caseChipmakers are re-tooling for AI, with new logic, memory and packaging, and they buy Applied's machines to do it; their spending plans must hold, not reset lower.
How we weighed it
The price against our value
Cuts both ways
Price at 94% of our value
The price is a little under our value, inside the margin both ways, with the bear case far below.
The business
In its favour
Solid
Machines chipmakers need for each layer of a chip, at record results.
Growth against what the price assumes
Cuts both ways
Growth is strong now; the price already counts on more of it.
What could go wrong
Against it
A minimum tax will raise the bill, China sales sit under licences, and insiders sold near the top.
Against competitors
Cuts both ways
The cheapest of its filed rivals on profit, but not on cash.
How its group is behaving
Cuts both ways
Chip-equipment names move together on news about chipmakers' spending.
The latest news and report
Cuts both ways
A record year and a quarter above its guide, and the call saw chip-equipment spending rising again next year, but free cash flow rose far less than profit as customers owed more, the tax rate stayed low, and the call addressed neither.
The evidence under this - 8 claims
Q4 net income of $2,718M carried a $653M unrealized loss on strategic investments, so the quarter's official profit understates the operations while the nine months' gains had flattered them (C06).
- Q4 converted well: free cash flow of $2,616M was 96% of the quarter's net income, so the year's shortfall sits in the first half (C10).
- Contract liabilities rose $1,019M in the year, customers paying ahead, the opposite signal to the receivable build (C11).
- Part of the fall is a prior-year effect rather than a current-year benefit: the $410M alternative minimum tax valuation allowance sat in fiscal 2025 and made that base rate unusually high.
- The One Big Beautiful Bill Act raised the CHIPS Act investment tax credit from 25% to 35% for qualifying property placed in service after 31 December 2025 and allows immediate expensing of domestic research costs, so part of the lower rate is enacted law rather than a one-off.
- Applied reports a record $3,037M of operating cash flow in Q3 alone, and $2,330M of non-GAAP free cash flow in the quarter against $2,050M a year earlier - so the nine-month shortfall was made in the first half and the quarter itself converted well.
- Capital expenditure is rising deliberately: management says fiscal 2026 will be a higher-than-normal capital spending year and that capital spending will fall as a share of revenue in 2027.
- Contract liabilities rose $698M, which is customers paying ahead for tools not yet delivered, and is the opposite signal to the receivable build.
- Applied's own explanation is mechanical rather than commercial: days sales outstanding rose to 77 from 72 because of higher down-payment invoices for revenue not yet recognised and because it factored fewer receivables than a year earlier. Neither is a change in the terms on which tools are sold.
- Neither reason is quantified anywhere in the filing, and the two run in opposite directions as evidence: down-payment invoicing means customers are paying earlier, while less factoring means Applied chose to carry the receivable itself rather than sell it. The second is a financing decision, not a demand signal.
- Days sales outstanding of 77 is high for a company whose revenue is recognised on delivery, and it moved five days in a year in which revenue rose 11.4% - so the change is larger than growth alone accounts for.
- The six-year median spans fiscal years in which revenue grew 2.5% and 4.4% and the operating margin sat near 29%; the business guided for Q4 fiscal 2026 is growing 50.7% at a 33.7% operating margin, so the two periods are not the same company at the same point in its cycle.
- Applied's filed competitor cohort trades higher on every earnings and sales multiple, and the whole cohort's earnings multiple has moved with Applied's in both directions - down over the nine days to 16 September and up by almost exactly the same proportion in the seven sessions to 25 September - so most of each repricing is the trade's rather than the company's.
- The multiple is struck on GAAP earnings that are themselves flattered this year: on Applied's own adjusted definition, trailing adjusted earnings of $10.91 a share, the trailing multiple is 44.5 times rather than 41.6.
- 2026-09-27editedRe-struck at the 25 September 2026 close of $485.00 after a 16.8% rise from $415.38; every multiple, the cash yield and the market value re-read from the refreshed research pack, the six-year medians unchanged.
- Applied is also the slowest-growing member of that cohort over the trailing twelve months and carries its lowest gross margin, so the discount is consistent with what the cohort's own figures say about the business rather than being unexplained.
- The whole cohort re-prices with Applied in both directions: at the 16 and the 25 September closes alike Applied sat at about three quarters of the cohort's median earnings multiple, just above the threshold below which a cohort may move a valuation score at all.
- 2026-09-27editedRe-read against the refreshed cohort at the 25 September 2026 close: still the lowest earnings multiple of the four, at about three quarters of the cohort median as before, because the cohort rose with Applied.
The company
A chip is built on a silicon disc, layer by layer. Applied sells the machines for seven of the steps: laying films down, growing crystal, etching material away, polishing flat, firing in atoms, heating, and measuring what the others did. Its buyers are the companies that own the chip factories.
A second business sells the spare parts, upgrades and servicing that keep those machines running.
The evidence under this - 1 claim
How it makes money
Most of it comes from selling machines: $7.04B of the June quarter's $9.12B. Each is a large sale to one of a handful of chipmakers, and two customers the filings never name buy about a third. The steadier fifth is servicing machines already installed, at 30 cents of operating profit on the dollar.
The evidence under this - 3 claims
- Self-service is the cheapest thing a customer can insource and the least of it: spares and uptime, not the tool. Nothing read here shows a chipmaker qualifying its own deposition, etch, planarization or implant equipment at a leading-edge node.
- Applied's service revenue grew 18% over the first nine months of fiscal 2026 and its segment operating margin rose to 30.1% from 27.3%, which is not what a segment losing work to its own customers looks like.
Where the money comes from, stream by stream
| Stream | Share of sales (Q3 fiscal 2026) | How it earns it |
|---|---|---|
| Chipmaking equipment for foundry, logic and other | about 52% (67% of Semiconductor Systems) | Deposition, etch, implant, polishing and inspection tools sold to contract foundries and logic chipmakers building leading-edge factories. |
| Chipmaking equipment for DRAM | about 20% (26% of Semiconductor Systems) | The same tool families sold to memory makers moving DRAM to new technology nodes and high-bandwidth memory. |
| Chipmaking equipment for NAND flash | about 5% (7% of Semiconductor Systems) | Tools sold to flash-memory makers adding layers to storage chips. |
| Applied Global Services | 20% | Spare parts, long-term service agreements and upgrades for the installed base of Applied tools. |
| Other (display) | 3% | Equipment for making display panels, now reported in Corporate and Other. |
Who runs it
Gary Dickerson has run Applied since 2013, after running a smaller chip-tool maker Applied bought; Brice Hill has run its finances since 2022. Insiders own well under 1% of the company, so they act as managers more than owners. The yearly bonus pays only once adjusted profit clears a bar. Most of the chief executive's pay is shares that vest on profit above the cost of the money tied up in the business, and on beating the stock market.
The evidence under this - 3 claims
- The 2020 long-term value-creation awards to Dickerson and Raja vested in full at the end of fiscal 2025 on the share price alone, which moves with the whole equipment cohort (C40).
- The fiscal 2023 to 2025 PSUs paid above target on non-GAAP operating margin, a figure that sat near 29% throughout those years (C50).
Why it wins, and who could beat it
Why customers come back
Once a chipmaker has approved a machine for a step, it keeps it. Proving a new one costs engineering time and wasted wafers, so the choice is made once per step for each chip generation.
The evidence comes from a rival. Lam Research's own annual report says it struggles to sell to a customer that has approved a competitor's machine, and names Applied as that competitor in depositing and etching. Applied's gross margin has risen from a year earlier for 13 quarters running.
The evidence under this - 3 claims
- The same filing qualifies the lock-in: the selection holds only 'as long as the supplier's products demonstrate performance to specification in the installed base', and it is stated per production-line application and per technology node - so every node transition reopens the decision, and Applied's largest customers are transitioning nodes continuously.
- It also notes competition from third-party spare-parts providers on the service half, which is 20% of Applied's revenue and the higher-retention part of it.
The threat
The threat is in China, 28% of June-quarter sales. US export rules have already closed part of that market, and Applied says they have raised its exposure to local rivals. ACM Research's own annual report names two, NAURA and Suzhou Jingtuo, at steps Applied sells into.
The evidence under this - 3 claims
- China revenue fell 2% year on year in Q3 fiscal 2026 while the total rose 25%, so the dependence is shrinking as a share even as the absolute figure holds. United States revenue doubled and Europe tripled in the same quarter.
- Management said on the Q3 call that it expects its China business and its wider trailing-edge business to grow in both calendar 2026 and 2027, having previously described a digestion period.
- The same filing warns that mainland China's state-led investment programme could produce overcapacity and price discounting rather than a durable competitor, which would hurt the entrants as much as the incumbents.
- Nothing in any filing read here shows a mainland China toolmaker qualified at a leading-edge foundry, logic or DRAM customer outside China, which is where 67% of Applied's Semiconductor Systems revenue sits.
- Self-service is the cheapest thing a customer can insource and the least of it: spares and uptime, not the tool. Nothing read here shows a chipmaker qualifying its own deposition, etch, planarization or implant equipment at a leading-edge node.
- Applied's service revenue grew 18% over the first nine months of fiscal 2026 and its segment operating margin rose to 30.1% from 27.3%, which is not what a segment losing work to its own customers looks like.
The rivals: LRCX, KLAC, ONTO, ACMR, KLIC, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | How far along | Priced against it |
|---|---|---|---|
| NAURA Technology Group Co., Ltd.Priced against it: Listed abroad | On sale | Listed abroad | |
| Private | Suzhou Jingtuo Semiconductor Technology Co., Ltd.Priced against it: Private | On sale | Private |
| LRCX | Lam Research CorporationPriced against it: Yes | On sale | Yes |
| SEMES Co., Ltd.Priced against it: Listed abroad | On sale | Listed abroad | |
| KLAC | KLAPriced against it: Yes | On sale | Yes |
| ONTO | Onto InnovationPriced against it: Yes | On sale | Yes |
| ACMR | ACM ResearchPriced against it: Shown, not counted | On sale | Shown, not counted |
| KLIC | Kulicke and Soffa IndustriesPriced against it: One segment only | On sale | One segment only |
How big it could get
How big this could get
Two customers alone plan $79B to $83B of factory spending in 2026: TSMC $52B to $56B, up from $40.9B last year, and Micron about $27B.
The market can grow even when factories do not. TSMC's capacity barely moved in 2025 while its spending rose about 33%, so each wafer is taking more equipment.
The evidence under this - 3 claims
- The same filing says the 2026 figure 'depending on market conditions, may be adjusted later', so it is a plan rather than a commitment, and TSMC has adjusted it before.
- A capital plan is not an equipment order. Most of the increase may sit in buildings, cleanroom shell and utilities rather than in process tools, and the filing does not split it.
- It is stated net of government incentives and Micron says the actual amount will vary with market conditions and with the timing of those incentives, so the gross figure and the phasing are both unstated.
- Memory capital spending is the most cyclical part of the equipment market: Micron's own risk factors describe the threat of oversupply from significant investment by Chinese state-affiliated entities.
- 2026-11-10editedexpired in October; re-sourced to Micron's fiscal 2026 annual report, which adds the fiscal 2027 estimate; the 2026 estimate the prize build uses is kept
Who has signed
Less than it looks. The only orders on hand anyone outside can check are $15.0B at October 2025, of which $7.1B is machines, and Applied says they can be amended or cancelled. Management points instead to its customers' eight-quarter forecasts, which are not orders and appear in no filing.
The evidence under this - 2 claims
- Management describes a detailed 8-quarter rolling forecast from its largest customers and roughly five years of roadmap visibility, and says customers now place longer-lead purchase orders and accept cancellation and expedite charges. That is more forward information than the backlog line carries - but it is a forecast the customer supplies, not an order it has placed, and none of it is filed.
- The equipment backlog is small relative to shipments by construction, because Applied recognises revenue on delivery rather than over a contract term. The service backlog is larger than the equipment backlog on a quarter of the revenue for the same structural reason.
- Asked directly by an analyst whether it would commit to growing systems revenue 40% or more, the chief financial officer declined, saying only that Applied expects to outgrow the market.
- The same call disclosed that the capacity Applied is building is explicitly not a revenue forecast - asked whether doubling manufacturing capacity meant doubling revenue by 2028, the chief financial officer said it should be taken as capacity only.
- 2026-11-10editedexpired in October; the 13 August call is still the latest management statement on 2026 and 2027 growth, and the 12 November results re-test it, so its shelf life is tied to that print
- 2026-11-12editedthe Q4 release puts calendar 2026 equipment growth above 40%
- 2026-11-13editedthe Q4 fiscal 2026 call gave the calendar 2027 equipment-market view and the output plan
The results
The numbers
Sales grew 7.8% over the twelve months to Jul 2026, about the same pace as the 4.4% in the year to Oct 2025.
Operating margin is 30%, about where it was (29%) in the year to Oct 2023.
Running costs take 20¢ of each sales dollar, up from 17¢ in the year to Oct 2021.
Each dollar put into the business earns 26% a year after tax, down from 36% in the year to Oct 2021.
It turned 18% of sales into free cash, $5.62B over the last twelve months.
It holds $9.23B of cash against $7.74B of debt, $1.49B more cash than it owes.
The share count fell 13% in 4.7 years, and pay in shares costs 2.2% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in October.
| Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 | 12 mo to Jul 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $23.1B | $25.8B | $26.5B | $27.2B | $28.4B | $30.8B |
| Sales growth | +34% | +12% | +2.8% | +2.5% | +4.4% | +7.8% |
| Profit | ||||||
| Gross margin | 47% | 47% | 47% | 47% | 49% | 49% |
| Operating margin | 30% | 30% | 29% | 29% | 29% | 30% |
| Net margin | 26% | 25% | 26% | 26% | 25% | 30% |
| What growth costs, per sales dollar | ||||||
| Research and development | 11% | 11% | 12% | 12% | 13% | 13% |
| Sales and marketing | 2.6% | 2.7% | 2.9% | 3.1% | 3.0% | 3.0% |
| General and admin | 2.7% | 2.9% | 3.2% | 3.5% | 3.2% | 2.5% |
| Pay in shares | 1.5% | 1.6% | 1.8% | 2.1% | 2.3% | 2.2% |
| Capital spending | 2.9% | 3.1% | 4.2% | 4.4% | 8.0% | 9.0% |
| Cash | ||||||
| Cash from operations | $5.44B | $5.40B | $8.70B | $8.68B | $7.96B | $8.40B |
| Free cash flow | $4.77B | $4.61B | $7.59B | $7.49B | $5.70B | $5.62B |
| Balance sheet | ||||||
| Cash and short-term investments | $5.46B | $2.58B | $6.87B | $9.47B | $8.57B | $9.23B |
| Debt | $5.45B | $5.46B | $5.56B | $6.96B | $6.55B | $7.74B |
| Net cash | $7.00M | −$2.88B | $1.31B | $2.51B | $2.02B | $1.49B |
| Returns and shares | ||||||
| Return on capital | 36% | 38% | 34% | 29% | 24% | 26% |
| Shares (diluted) | 919M | 877M | 845M | 834M | 808M | 800M |
What growth costs
Growth has not yet made Applied more profitable. It keeps more of each sale after building the machines, but it spends that gain on research and on new labs and factories, so the share of sales left as operating profit has barely moved in three years.
The evidence under this - 1 claim
- Fiscal 2025 carries a $181M restructuring charge and the nine months to July 2026 a $253M export-controls settlement (C27), so the operating margin understates the underlying one in both periods.
- Capital spending includes the Singapore campus and the EPIC Center (C41), which are capacity and research facilities rather than a cost that recurs with each sale.
The last report (12 Nov)
Quarter ended July 2026, filed figures.
The fourth quarter of fiscal 2026, ended 25 October, brought record sales of $10.41B, up 53% and above the company's forecast, with memory-chip makers buying a larger share of the machines. The full year's sales rose 21% to $34.45B and profit 44%.
The cash told a smaller story. Free cash flow rose 9% to $6.20B, with a record $2.62B in the last quarter, but unpaid customer bills reached $9.0B, up 73.5% on sales up 21%. The tax rate stayed near 12.6%, half of last year's. On the call Applied guided the next quarter to $11.1B and said chip-equipment spending should rise over 30% in 2027.
What it did to the thesisIt confirmed a stronger business and lifted our value a little. It did not settle the doubt about cash: the last quarter converted well, but over the year unpaid bills grew far faster than sales, the low tax rate held, and the call addressed neither.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $4.16 against $4.06 expected.
The evidence under this - 6 claims
Q4 net income of $2,718M carried a $653M unrealized loss on strategic investments, so the quarter's official profit understates the operations while the nine months' gains had flattered them (C06).
- Q4 converted well: free cash flow of $2,616M was 96% of the quarter's net income, so the year's shortfall sits in the first half (C10).
- Contract liabilities rose $1,019M in the year, customers paying ahead, the opposite signal to the receivable build (C11).
- Applied has beaten its own revenue and earnings guidance in each of the last eight reported quarters, so the guide has been conservative rather than stretched.
- Against that, management guided company gross margin flat on a 12.4% sequential revenue increase, attributing it to the cost of ramping customer service engineers and to the display business growing inside the Other line - so the guided revenue does not carry guided operating leverage with it.
- 2026-11-12editedQ4 delivered against the guide; the Q1 fiscal 2027 guide replaces it
- Part of the fall is a prior-year effect rather than a current-year benefit: the $410M alternative minimum tax valuation allowance sat in fiscal 2025 and made that base rate unusually high.
- The One Big Beautiful Bill Act raised the CHIPS Act investment tax credit from 25% to 35% for qualifying property placed in service after 31 December 2025 and allows immediate expensing of domestic research costs, so part of the lower rate is enacted law rather than a one-off.
- Contract liabilities rose $698M, which is customers paying ahead for tools not yet delivered, and is the opposite signal to the receivable build.
- Applied's own explanation is mechanical rather than commercial: days sales outstanding rose to 77 from 72 because of higher down-payment invoices for revenue not yet recognised and because it factored fewer receivables than a year earlier. Neither is a change in the terms on which tools are sold.
- Asked directly by an analyst whether it would commit to growing systems revenue 40% or more, the chief financial officer declined, saying only that Applied expects to outgrow the market.
- The same call disclosed that the capacity Applied is building is explicitly not a revenue forecast - asked whether doubling manufacturing capacity meant doubling revenue by 2028, the chief financial officer said it should be taken as capacity only.
- 2026-11-10editedexpired in October; the 13 August call is still the latest management statement on 2026 and 2027 growth, and the 12 November results re-test it, so its shelf life is tied to that print
- 2026-11-12editedthe Q4 release puts calendar 2026 equipment growth above 40%
- 2026-11-13editedthe Q4 fiscal 2026 call gave the calendar 2027 equipment-market view and the output plan
What management did with the money
It slowed its buybacks sharply, to 3 million shares for $1.14B in nine months against 25 million for $4.0B a year earlier. It holds $14.5B of cash and investments against $6.5B of bonds.
Insiders in 2026Q2: 0 purchases and 39 sales, from their Form 4 filings.
The evidence under this - 2 claims
- 2026-11-12editedthe fiscal 2026 year-end balance sheet from the release
The price, and where we disagree
In short. Fair. The price is about 94% of what we think the business is worth, at an 8% yearly return.
The shares fell 34.4% from their June high to late September, then recovered part of it, while every operating number set records. Three sharp drops came on worries about how long factory spending lasts, none with a cut to analysts' forecasts.
The year's results answered how big the boom is, not whether its cash arrives. The next test is the first quarter of fiscal 2027, around February: whether unpaid bills finally fall, and what profit looks like once the tax rate rises.
The evidence under this - 6 claims
- 2026-09-27editedRe-struck at the 25 September 2026 close of $485.00: the drawdown from the June high narrowed from 43.8% to 34.4% and the 16.8% rebound since 16 September is now part of the current state.
- The fiscal 2027 revenue figure rests on 23 estimates and requires growth of about 36% on a fiscal 2026 that Applied's own guidance already puts at about 21% growth - two consecutive years of acceleration in a business whose eight-year compound revenue growth rate to fiscal 2025 was 7.9% with one year of decline.
- A panel that barely moved through an 11.7% fall and the 16.8% rise that followed is as consistent with estimates that have not yet been revised as with estimates nobody thinks need revising. The next scheduled occasion to move them is the Q4 print on 12 November 2026.
- 2026-09-27editedRe-read from the refreshed research pack of 27 September 2026: fiscal 2027 estimates edged up to $46.75B and $18.71 while the price rose 16.8%; the rating split is unchanged.
- Q4 converted well: free cash flow of $2,616M was 96% of the quarter's net income, so the year's shortfall sits in the first half (C10).
- Contract liabilities rose $1,019M in the year, customers paying ahead, the opposite signal to the receivable build (C11).
- Part of the fall is a prior-year effect rather than a current-year benefit: the $410M alternative minimum tax valuation allowance sat in fiscal 2025 and made that base rate unusually high.
- The One Big Beautiful Bill Act raised the CHIPS Act investment tax credit from 25% to 35% for qualifying property placed in service after 31 December 2025 and allows immediate expensing of domestic research costs, so part of the lower rate is enacted law rather than a one-off.
- Applied has beaten its own revenue and earnings guidance in each of the last eight reported quarters, so the guide has been conservative rather than stretched.
- Against that, management guided company gross margin flat on a 12.4% sequential revenue increase, attributing it to the cost of ramping customer service engineers and to the display business growing inside the Other line - so the guided revenue does not carry guided operating leverage with it.
- 2026-11-12editedQ4 delivered against the guide; the Q1 fiscal 2027 guide replaces it
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 18%, 11%, 4.9% | 35.9%, 22%, 9.8% | 44.9%, 27.5%, 12.3% |
| Normal operating margin | 28.2% | 35.3% | 38.8% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $204 | $422 | $583 |
- Price
- $395
- Priced on
- 11 Nov
- Price as a share of the base value
- 94%
- Starting growth the price pays for
- 22.6%
- Yearly return the price offers on the base case
- 8.3%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $285
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last full year | Filed report | Filed report (8-K) for the period to 25 Oct 2026, filed 12 Nov 2026; the full year. |
| Operating margin today | Filed report | Filed report (8-K) for the period to 25 Oct 2026, filed 12 Nov 2026; the full year. |
| Tax rate | Filed report | Quarterly report (10-Q) for the period to 26 Jul 2026, filed 20 Aug 2026; the four quarters to that date. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 26 Oct 2025, filed 12 Dec 2025: the year's sales over its operating capital. |
| Shares | Filed report | Filed report (8-K) for the period to 25 Oct 2026, filed 12 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Filed report (8-K) for the period to 25 Oct 2026, filed 12 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Filed report (8-K) for the period to 25 Oct 2026, filed 12 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 26 Oct 2027, 26 Oct 2028 and 26 Oct 2029: the average of 4 to 28 analysts' revenue estimates, 35.9%, 22%, 9.8%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Filed report | The best operating margin it has filed before amortisation of past deals, over five years and the latest quarter: a cyclical business is held to its record. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 11 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 18%, 11% and 5%, the margin settles a fifth lower at 28.2%, and new capital earns only the 8% rate: the downturn test.
Base caseFiscal 2026 sales of $34.45B grow 36%, 22% and 10% over three years, the analysts' path (C54), then fade toward 4%, closing 30% of the gap each year; the margin moves to 35.3%, what its October 2026 quarter earned before amortisation of past deals, not the analysts' higher figure; a cyclical business's normal margin goes no higher than it has already filed.
Bull caseGrowth runs a quarter above the analysts' path, 45%, 28% and 12%, the margin reaches 38.8%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $358 | $494 |
| The normal margin, 15% lower or higher | $362 | $482 |
| Capital per dollar of growth, a quarter more or less | $417 | $425 |
| Return on new capital after year ten, at the rate or one step up | $342 | $454 |
| The rate, a point higher or lower | $340 | $558 |
| Long-run growth a point lower | $382 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 28.2% | $247 | $291 | $342 | $399 | $464 |
| 31.8% | $275 | $325 | $382 | $446 | $519 |
| 35.3% | $303 | $358 | $422 | $494 | $575 |
| 38.8% | $331 | $392 | $462 | $541 | $631 |
| 42.4% | $359 | $426 | $502 | $588 | $686 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Buyers pay about 41.6 times last year's profit, against its usual 18.7 times over six years. Its spare cash is only 1.5% of the price a year, against a normal 5.4%. Rivals cost more on profit, but not on cash.
On analysts' forecasts the price looks lower, but only if:
- Sales this year reached $34.45B, as the company guided.
- Sales then jump to about $46.9B in fiscal 2027, as analysts expect.
- Then today's price is about 21 times that year's profit: fair only if the boom proves permanent.
Against its own history. Far dearer than its own normal on profit and on cash, while the business is also at its peak: peak prices for peak profit.
The evidence under this - 8 claims
- The six-year median spans fiscal years in which revenue grew 2.5% and 4.4% and the operating margin sat near 29%; the business guided for Q4 fiscal 2026 is growing 50.7% at a 33.7% operating margin, so the two periods are not the same company at the same point in its cycle.
- Applied's filed competitor cohort trades higher on every earnings and sales multiple, and the whole cohort's earnings multiple has moved with Applied's in both directions - down over the nine days to 16 September and up by almost exactly the same proportion in the seven sessions to 25 September - so most of each repricing is the trade's rather than the company's.
- The multiple is struck on GAAP earnings that are themselves flattered this year: on Applied's own adjusted definition, trailing adjusted earnings of $10.91 a share, the trailing multiple is 44.5 times rather than 41.6.
- 2026-09-27editedRe-struck at the 25 September 2026 close of $485.00 after a 16.8% rise from $415.38; every multiple, the cash yield and the market value re-read from the refreshed research pack, the six-year medians unchanged.
- Applied is also the slowest-growing member of that cohort over the trailing twelve months and carries its lowest gross margin, so the discount is consistent with what the cohort's own figures say about the business rather than being unexplained.
- The whole cohort re-prices with Applied in both directions: at the 16 and the 25 September closes alike Applied sat at about three quarters of the cohort's median earnings multiple, just above the threshold below which a cohort may move a valuation score at all.
- 2026-09-27editedRe-read against the refreshed cohort at the 25 September 2026 close: still the lowest earnings multiple of the four, at about three quarters of the cohort median as before, because the cohort rose with Applied.
- 2026-09-27editedRe-read against the refreshed cohort at the 25 September 2026 close: still third of four on price to free cash flow and above the median; every other ranking unchanged.
- The fiscal 2027 revenue figure rests on 23 estimates and requires growth of about 36% on a fiscal 2026 that Applied's own guidance already puts at about 21% growth - two consecutive years of acceleration in a business whose eight-year compound revenue growth rate to fiscal 2025 was 7.9% with one year of decline.
- A panel that barely moved through an 11.7% fall and the 16.8% rise that followed is as consistent with estimates that have not yet been revised as with estimates nobody thinks need revising. The next scheduled occasion to move them is the Q4 print on 12 November 2026.
- 2026-09-27editedRe-read from the refreshed research pack of 27 September 2026: fiscal 2027 estimates edged up to $46.75B and $18.71 while the price rose 16.8%; the rating split is unchanged.
- The Q4 guide has been beaten in each of the last eight quarters, so $12.76 is more likely a floor than a midpoint, and a beat lowers the multiple.
- The fiscal 2027 figure is a vendor consensus struck on the adjusted definition and carries no contracted order book behind it; the only equipment backlog anyone outside can check is one quarter of the guided shipment rate.
- 2026-09-27editedRe-struck at the 25 September 2026 close of $485.00 and the refreshed fiscal 2027 consensus of $18.71; the guidance arithmetic is unchanged.
An average of a handful of forecasts that has moved with each print; the company's own guidance covers at most the next year, and the analysts' operating profit is usually the adjusted figure, before stock pay.
- 2026-11-12editedre-read after the fiscal 2026 print; fiscal 2029 added for the third year of the path
The value leans on the analysts' path, which this thesis has not tested name by name, and on a 15% tax rate the global minimum tax is expected to raise; at a 10% required return it is about $285, and the bear case of $204 is the downturn test.
- 2026-11-09editedgrowth fades as each year closes 30% of its gap to 4% and the analysts' margin is put on the filed basis, the owner's call of 9 November
- 2026-11-10editeda cyclical business's normal margin held to what it has already filed, and a tax rate kept low by past losses raised to 21%, the owner's rules of 10 November
- 2026-11-10editedprice re-read at the 9 November close, $370.55; the inputs and the $423 base case did not move
- 2026-11-10editedre-valued on the owner's rules of 10 November: the return on new capital glides to its terminal level over years six to ten
- 2026-11-12editedre-valued on the fiscal 2026 results: the base moves from fiscal 2026's filed year, the margin to the October quarter's 35.3%, debt read from the balance sheet; base about $422, the 11 November price about 94% of it
Q4 net income of $2,718M carried a $653M unrealized loss on strategic investments, so the quarter's official profit understates the operations while the nine months' gains had flattered them (C06).
Priced against its rivals
The competitors its own annual report names, each confirmed against the rival's filing. Measured on price for each $1 of yearly profit, cheapest first:
| Ticker | Company | price for each $1 of yearly profit |
|---|---|---|
| AMAT | Applied Materials | 41.6× |
| KLAC | KLA | 51.0× |
| LRCX | Lam Research | 54.4× |
| ONTO | Onto Innovation | 107.3× |
| ACMR | ACM Research not in the median | 34.4× |
The middle of the other 3 is 54.4. ACM Research, Inc. competes with it in one product line inside a much bigger company, so its price says little about this business and it is not counted in the middle. Applied Materials, Inc. is cheapest of 4.
Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.
The cheapest of its filed rivals on profit but not on cash, which is exactly where this thesis says Applied's profit and cash part company.
Also checked and set aside: ASML Holding (a substitute, not the same product).
Private or foreign rivals that cannot be priced: Tokyo Electron Limited, NAURA Technology Group Co., Ltd., ASM International N.V., Hitachi High-Tech, SCREEN Holdings, SEMES and Kokusai Semiconductor Equipment.
Where we disagree with the market
Applied is the broadest way to own the AI build-out, and the fall since June has made a very good business cheap again.
The business is stronger, but its reported profit is flattered twice: by a halved tax rate and by paper gains on investments.
The usual check points the wrong way. Applied's own adjusted earnings sit below its reported ones this year, and only the cash-flow statement shows the unpaid bills.
We are wrong if November delivers the promised sales with unpaid bills falling and full-year cash above $5.70B.
What analysts say, and the evidence
The evidence under this - 4 claims
- Applied publishes the reconciliation prominently in its own release and guides Q4 on the adjusted basis, so this is disclosed rather than hidden, and the fiscal 2027 consensus is struck on the adjusted definition.
- The direction was the other way round a year earlier: nine-month fiscal 2025 GAAP earnings of $6.29 sat below non-GAAP of $7.25, because that period carried a $644M Singapore deferred-tax remeasurement and a $410M valuation allowance against alternative minimum tax credits.
- Contract liabilities rose $698M, which is customers paying ahead for tools not yet delivered, and is the opposite signal to the receivable build.
- Applied's own explanation is mechanical rather than commercial: days sales outstanding rose to 77 from 72 because of higher down-payment invoices for revenue not yet recognised and because it factored fewer receivables than a year earlier. Neither is a change in the terms on which tools are sold.
- Applied has beaten its own revenue and earnings guidance in each of the last eight reported quarters, so the guide has been conservative rather than stretched.
- Against that, management guided company gross margin flat on a 12.4% sequential revenue increase, attributing it to the cost of ramping customer service engineers and to the display business growing inside the Other line - so the guided revenue does not carry guided operating leverage with it.
- 2026-11-12editedQ4 delivered against the guide; the Q1 fiscal 2027 guide replaces it
- Applied reports a record $3,037M of operating cash flow in Q3 alone, and $2,330M of non-GAAP free cash flow in the quarter against $2,050M a year earlier - so the nine-month shortfall was made in the first half and the quarter itself converted well.
- Capital expenditure is rising deliberately: management says fiscal 2026 will be a higher-than-normal capital spending year and that capital spending will fall as a share of revenue in 2027.
What could go wrong, and how we would know
The risks
- The tax bill comes back. Applied says a new global minimum tax should materially raise its foreign taxes. Instead the rate halved, and a return would cut reported profit.
- China and export rules. China was 28% of sales under US licences that can be withdrawn, and a $253M export-rules settlement may not be the last.
- Insiders selling near the top. 44 open-market sales and no purchases in a year; the chief executive sold within days of the June high.
The evidence under this - 5 claims
- Part of the fall is a prior-year effect rather than a current-year benefit: the $410M alternative minimum tax valuation allowance sat in fiscal 2025 and made that base rate unusually high.
- The One Big Beautiful Bill Act raised the CHIPS Act investment tax credit from 25% to 35% for qualifying property placed in service after 31 December 2025 and allows immediate expensing of domestic research costs, so part of the lower rate is enacted law rather than a one-off.
The rate has fallen rather than risen in the period the company said the increase would begin, so either the Singapore incentive remeasurement is offsetting the minimum tax or the effect is still to come. The filing does not quantify either side.
- China revenue fell 2% year on year in Q3 fiscal 2026 while the total rose 25%, so the dependence is shrinking as a share even as the absolute figure holds. United States revenue doubled and Europe tripled in the same quarter.
- Management said on the Q3 call that it expects its China business and its wider trailing-edge business to grow in both calendar 2026 and 2027, having previously described a digestion period.
- The chief executive still held 1,599,873 shares after the sales, so he sold under 5% of his position.
- The filings read here do not say whether the sales were made under a pre-arranged trading plan, and the pack transcribes Form 4 without the plan footnote, so no inference about timing is available from this evidence alone.
- 2026-09-27editedRe-read from the refreshed research pack of 27 September 2026, as the claim's refresh_by required: no open-market trade filed since the 8 September director sale, and the count and the named sales are unchanged.
What we still do not know
- Who the two customers taking a third of sales are. No filing names either.
- How much of the $2.51B of unpaid bills is down payments invoiced early and how much is Applied selling fewer of its bills to banks. The filing sizes neither.
The evidence under this - 3 claims
- Contract liabilities rose $698M, which is customers paying ahead for tools not yet delivered, and is the opposite signal to the receivable build.
- Applied's own explanation is mechanical rather than commercial: days sales outstanding rose to 77 from 72 because of higher down-payment invoices for revenue not yet recognised and because it factored fewer receivables than a year earlier. Neither is a change in the terms on which tools are sold.
- Neither reason is quantified anywhere in the filing, and the two run in opposite directions as evidence: down-payment invoicing means customers are paying earlier, while less factoring means Applied chose to carry the receivable itself rather than sell it. The second is a financing decision, not a demand signal.
- Days sales outstanding of 77 is high for a company whose revenue is recognised on delivery, and it moved five days in a year in which revenue rose 11.4% - so the change is larger than growth alone accounts for.
What would change our view
- Neutral→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $337, 80% of what we think the business is worth.about $337.02 today, 31% below the last close
- Neutral→UnattractiveThe price runs 20% above fair value
It needs:
- ○The share price rises to about $506, 20% above what we think the business is worth.about $504.89 today, 4% above the last close
We would also be wrong if
- The tax rate returns above 25% and adjusted earnings per share still grow.
- Applied publishes signed orders covering several years, in a filing or at an investor event.
What is coming
- December 2026 Fiscal 2026 annual report (10-K): Year-end backlog against $15,002M, the two large customers' shares, and whether the export-controls subpoenas have closed.
Every dated event ahead
- December 2026 Fiscal 2026 annual report (10-K): Year-end backlog against $15,002M, the two large customers' shares, and whether the export-controls subpoenas have closed.
- January 2027 2027 proxy statement: What the fiscal 2026 bonus paid on, whether the pay metrics change again, and what insiders own after the 2026 sales.
- February 2027 Q1 fiscal 2027 results: Whether receivables fall against the $11.1B guide, whether the tax rate rises under the minimum tax, and whether calendar 2026 equipment growth lands above 40%.
Since we wrote this
- 13 NovEarningsThe call sees a stronger 2027 but skips the cash; Neutral holdsManagement expects chip-equipment spending to rise over 30% next year, which the analysts' path already carries. Nobody asked about unpaid bills or the tax rate, so the doubts stand and our value did not move.
- 12 NovEarningsRecord year above its guide; cash lagged profit, view holds NeutralSales rose 21% and profit 44% in fiscal 2026, but free cash flow rose 9% as unpaid bills grew. Our value rose slightly and the price sits inside our band.
- 10 NovThesis reviewStill Attractive: priced at 79% of a value near $423Re-valued on the rules for cyclical margins and loss-history tax.
- 10 NovPrice moveNeutral: priced at 88% of a value near $423The price rose past route P1: 88% of the three-stage value is inside the 20% margin of safety, so the view moves to Neutral ahead of the 12 November results.
- 9 NovThesis reviewAttractive: priced at 74% of a value near $451Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits past the 20% margin of safety.
- 26 OctNewsApplied will raise its Besi stake to about 20%A capped stake in a hybrid-bonding partner; the price is undisclosed, so the view held.
- 5 OctThesis reviewThe long case now sits under the verdictAfter the five-name pilot, the owner asked for the long case on every thesis.
- 4 OctThesis reviewOwner's checklist: revenue streams, cost of growth, management, catalystsThe owner's checklist found the method silent on who runs the company, what growth costs, where the money comes from and what is dated ahead; this pass fills those four blocks from the proxy and filings.
- 2 OctNewsBesi joins Applied's EPIC Center to co-develop chip packaging; no order or term disclosed. View heldBesi joins Applied's EPIC Center as an Innovation Partner.
- 27 SepPrice moveShares back up 16.8%, all of September's fall. View heldNo results and no filing arrived. The price is again about 42 times last year's profit, more than twice the company's own normal, and the November cash-flow test is unchanged.
- 17 SepPrice moveShares down 11.7% with nothing else moved. View heldNo results and no filing arrived. The cheaper price still sits far above the company's own normal, and short sellers added 31.5% at the end of August.
- 8 SepThesis writtenNeutral, medium convictionEvery operating number was at a record, but nine-month cash fell while earnings per share rose 47%, mostly on tax and investment gains.
Also checked 7 times with nothing new to act on.
Sources 24
Sources - 24
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2025-12-12the business description and the list of process steps in each segment, the Competition section that names nobody, backlog of $15,002M at 26 October 2025 with its segment split and its 12-month conversion note, customer concentration of approximately 19% and 15% in fiscal 2025, the export-control and customer-concentration risk factors, the segment note explaining that Display sits in Corporate and Other, and the fiscal 2025 statementsbacksC01C13C16C17C21C36C44C47C50C51
- S02primarycompany filing2026-08-20the nine-month income statement and cash flow statement, the working-capital components including the $2,508M receivable build, the effective tax rate note and the global-minimum-tax paragraph, the stock repurchase note, days sales outstanding, the segment table including the Other operating loss, the geographic revenue split, customer concentration of approximately 20% and 14%, and the absence of any updated backlog figurebacksC02C04C05C08C09C10C11C12C14C15C16C17C25C27C29C31C39C46C50
- S03primarycompany filing2026-08-13the Q4 fiscal 2026 revenue and earnings guidance, the full GAAP-to-non-GAAP reconciliation showing nine-month adjusted earnings below reported earnings, the segment gross margins, the 200-millimetre reclassification and corporate-cost reallocation note, the six new systems, the EPIC Center engagements and the Singapore campusbacksC02C03C07C25C26C27C34C37C41
- S04primarycompany filing2025-11-13the fiscal 2025 full-year figures, fiscal 2025 free cash flow of $5,698M against $7,487M, and the Q1 fiscal 2026 guidance of $6,850M and $2.18 that the current quarterly guide should be read againstbacksC29C36
- S05primarytranscript2026-08-13management's answers on the calendar 2026 growth path, the 8-quarter customer forecast, the refusal to commit to a systems growth number, the statement that doubled capacity is not a revenue forecast, the flat gross margin guide and its ramp-cost explanation, and the advanced packaging, services and process-control growth figures that appear in no filing; also 28 analyst turns from 10 analysts, which is a separate origin from the answersbacksC28C38
- S06primarycompany filing2026-08-07a competitor's own statement of the qualification lock-in that is Applied's moat, its naming of Applied Materials as its primary competitor in deposition and among its primary competitors in etch, and its own China revenue share of 34%backsC19C20C44
- S07primarycompany filing2026-02named mainland China equipment competitors - NAURA Technology Group and Suzhou Jingtuo Semiconductor Technology - the statement that local entrants are appearing across multiple product lines, its naming of Applied Materials for deposition and track products, and its description of China's state-led supply-chain programmebacksC18C44
- S08primarycompany filing2026-04-16a customer's own filed capital plan - US$40,895M spent in 2025 and US$52 billion to US$56 billion expected in 2026 - and its annual capacity of more than 17 million 12-inch equivalent wafers against approximately 17 million a year earlierbacksC22C23C43
- S09primarycompany filing2026-06-25the memory side of the same customer capital plan - approximately $27 billion estimated for 2026 net of government incentives - and the $22 billion of customer deposits and financial commitments behind Micron's own strategic customer agreementsbacksC24C43
- S10primaryvendor data2026-09-27Research pack frozen at content/AMAT/research-pack.jsoncontent/AMAT/research-pack.jsonthe market tier - price, the multiple series against six-year medians, the analyst panel and its fiscal 2027 estimates, the 252-day return and drawdown, the measured reaction to the Q3 print, FINRA short interest, Form 4 insider transcription, the theme co-movement series - and the filed competitor cohort's multiplesbacksC29C30C31C32C33C34C40C42C45
- S11primarycompany filing2026-08-06the segment split used to set the cohort perimeter - Semiconductor Process Control at $12,244.7M of $13,579.2M - its description of the inspection and metrology products that overlap Applied's, and Taiwan Semiconductor as its only 10%-plus customer in each of three yearsread, but no claim rests on it
- S12primarycompany filing2026-02-24the third cohort member's own description of what it sells, and the risk factor disclosing that part of its metrology is integrated into other suppliers' process tools rather than sold against themread, but no claim rests on it
- S13primarycompany filing2026-05-14the middle point of the guidance path - the 'more than 30 percent' calendar 2026 semiconductor equipment growth statement raised again in August, and the quarter in which reported earnings per share of $3.51 first exceeded the adjusted $2.86backsC28
- S14primarycompany filing2026-01-28beneficial ownership of directors, officers and 5% holders as of December 31, 2025, the fiscal 2025 bonus hurdle, scorecard weights and payouts, the PSU metrics and the switch from operating margin to economic profit, the 2020 value-creation awards, the CEO's fiscal 2025 pay and the director biographiesbacksC47C48C49
- S15primarycompany filing2026-10-26the agreement to take its Besi holding to about 20%, subject to the HSR waiting period
would own approximately 20% of the outstanding shares of the common stock of Besi
backsC53 - S16primarycompany release2026-10-26the stated reason, no intention to go above 20% and no board seat
Applied currently has no intention to increase its investment in Besi beyond approximately 20 percent
backsC53 - S17primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC55
- S18secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC54
- S19secondaryvendor data2026-11-10the 9 November close of $370.55read, but no claim rests on it
- S20primaryregulator2026-11-10short interest of 14,179,138 shares at the 15 October 2026 settlement, 13,530,729 at 30 September, and days to coverbacksC42
- S21primarycompany filing2026-10-09Micron's estimate of capital expenditure net of government incentives: about $11.5 billion in the first quarter of fiscal 2027 and about $25 billion in the first six months, higher in the second halfbacksC24
- S22primarycompany release2026-11-12Q4 and fiscal 2026 income statement, balance sheet and cash flow, the segment table, the GAAP to non-GAAP reconciliation, geography, and the Q1 fiscal 2027 outlookbacksC03C15C28C55C56C57
- S23secondaryvendor data2026-11-12the 11 November close of $395.08, the Q4 adjusted EPS estimate of $4.06 and the analysts' fiscal 2027 to 2029 revenuebacksC54C55
- S24primarytranscript2026-11-12Q4 fiscal 2026 earnings call transcript (FMP), held 12 November 2026the calendar 2027 equipment-market view, advanced packaging, process control and services growth, the Q1 fiscal 2027 segment and tax outlook, the plan to double systems output by 2028, China below 25% of fiscal 2027 business, and 23 analyst turns from 11 analysts on demand, supply, margins, services and China
Our current view is that wafer fab equipment demand will be up more than 30% year-over-year, and we are in a strong position to outperform the market again.
backsC28C38